- Staat
- KY
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 22.12.2022
- Impfdatum
- 22.12.2022
- Beginn
- 22.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Syncope
Symptomtext
At approx 11:50 am, After administering the PPD (flu and COVID-19 shot given prior) the patient looked at the area where PPD was administered and fainted. He fainted for approx 5 seconds and then was alert and oriented x4. The patient reported he felt nauseous and might vomit, trash can brought to the patient where he spit in the can. Patient then got onto the exam table with feet slightly elevated for approx 10 mins. Patient reported he felt much better but due to APRN recommendations had his mother come and pick him up.His mother came and patient was alert and orientated x 4 when he left.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Aplisol PPD
- Allergien
- eggs
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 11.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Blood test normal
Dizziness postural
Head injury
Hypotension
Syncope
Symptomtext
patient fainted when she was at the register being released after receiving the vaccines Flublok Quad and the Shingrix. EMT's were called since she hit her head; they took her to hospital because when they were evaluating they asked her to stand and she became dizzy again and had really low blood pressure...Patient came back later today and states that she is fine her blood pressure, heart and blood work up all came back normal
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- PATIENT WS TAKEN TO EMERGENCY ROOM
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 67,0
- Geschlecht
- F
- Eingang
- 24.01.2023
- Impfdatum
- 23.11.2022
- Beginn
- 29.11.2022
- Tage bis Beginn
- 6,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injected limb mobility decreased
Injection site pain
Pain
Symptomtext
Within a week started to have severe pain left shoulder and inability to lift shoulder above 90 degrees due to pain - still ongoing but improving and first brought to provider attention at visit today. Referred to physical therapy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injected limb mobility decreased
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- Htn, Hx CVA 2015, prediabetes, psoriasis, COPD, GERD, hyperlipidemia, OA
- Andere Medikamente
- Breo Ellipta, Aspirin 81mg, amlodipine, atorvastatin, albuterol, tylenol, cyanocobalamin
- Allergien
- penicillin (hives)
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 05.01.2023
- Impfdatum
- 30.12.2022
- Beginn
- 30.12.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
C-reactive protein normal
Chest X-ray normal
Chest discomfort
Dizziness
Dyspnoea
Electrocardiogram normal
Erythema
Full blood count normal
Immediate post-injection reaction
Malaise
Metabolic function test normal
Pruritus
Pyrexia
Urine analysis normal
Symptomtext
onset was immediate after vaccinations. Patient c/o weakness, fever, chest tightness for past 2-3 days Got COVID booster on Friday and had to stay under observation for 2 hours after d/t concern for an allergic reaction Experienced dizziness, neck and chest were red and felt itchy Did not receive any medications and was eventually allowed to go home Since leaving has felt unwell Today had temperature of 100.5 F Entire body feels weak Chest tight and getting short of breathe more easily than usual
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- CXR - 01/04/2023 Impression: No acute cardiopulmonary abnormality. EKG - 01/03/2023 - NSR - negative for acute changes. CBC/CMP/CRP/UA - negative 01/03/2023
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- small fiber neuropathy, erythromelalgia, GERD, joint pain, migraines, raynauds, chronic pain syndrome
- Andere Medikamente
- nortriptyline 10 mg caps, 50 mg PO qHS ondansetron 4 mg RD tabs, DISSOLVE 1 TABLET BY MOUTH ONCE AS NEEDED FOR NAUSEA AND/OR VOMITING pantoprazole 40 mg DR tabs, 1 tab PO qhs pregabalin 75 mg caps, TAKE 2 CAPSULES BY MOUTH TWICE A DAY. DO N
- Allergien
- Paxil
- Vorherige Impfungen
- COVID-19 vaccine (moderna)
- Staat
- FL
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 26.10.2022
- Impfdatum
- 21.10.2022
- Beginn
- 22.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Condition aggravated
Fatigue
Headache
Inflammation
Neuralgia
Symptomtext
10/26/2022 reported to employee health that symptoms included chills, fatigue, severe headache, face inflammation and nerve pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- migraines, long covid nerve pain
- Andere Medikamente
- none known
- Allergien
- none
- Vorherige Impfungen
- 10/2021
- Staat
- WY
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 02.12.2022
- Impfdatum
- 28.11.2022
- Beginn
- 29.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site pain
Injection site pruritus
Pruritus
Vaccination site bruising
Symptomtext
Patient reported to ER with complaint of redness and itching of the arm after vaccination. Patient reports the day after the covid and flu shot she had some itching that would not go away on her right arm and thought that it was her sweater making her itch. This nurse noticed on the right arm slight redness below vaccination site with some bruising at vaccination site. Reports that it has not gotten any better or worse and is still itchy and tender. Does report that it feels better with cold compress. Redness measure 4.5 inches in length from shoulder to elbow, and 3.5 inches from outer arm to inner arm. Patient denied any shortness of breath, difficulty breathing, tightness in the chest, blurry vision or light headedness. Patient is taking atorvastatin, multivitamin and naproxen.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- rheumatoid arthritis
- Andere Medikamente
- Naproxen, Multivitamin, Atorvastatin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 09.11.2022
- Impfdatum
- 31.10.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Rash
Rash vesicular
Symptomtext
Patient states she developed a shingles rash on her across her left chest, under her left arm and onto her left upper back. Painful and blistery. Symptoms started two days after vaccinations. Patient prescribed Lidocaine cream.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- Amlodipine
- Allergien
- NSAIDS
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 27.10.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fatigue
Medication error
Product administered to patient of inappropriate age
Somnolence
Symptomtext
groggy night of vaccine; 6 yr old received Flublok which is licensed for 18 yrs and older; very tired; Initial information received on 14-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 6 years old female patient who was very tired, had groggy night of vaccine and received flublok which is licensed for 18 yrs and older while receiving vaccine influenza quadrivalent recombinant vaccine [Flublok Qiv]. The patient had no medical history, concomitant disease or risk factor. On 21-Sep-2022, the patient received a dose of suspect influenza quadrivalent recombinant vaccine lot UJ887AA (with an unknown dosage, strength, formulation, expiry date) via intramuscular route in unknown administration site for Flu. On 21-Sep-2022, the patient had developed a non-serious events groggy night of vaccine (somnolence), very tired (fatigue) and received flublok which is licensed for 18 yrs and older (product administered to patient of inappropriate age) latency same day following the administration of influenza quadrivalent recombinant vaccine. Patient reported that Back to baseline by following morning. There were no lab data/results available. Action taken - not applicable. It was not reported if the patient received a corrective treatment for the events. At time of reporting, the outcome was Recovered / Resolved in September 2022 for the event groggy night of vaccine and for the event very tired, was Unknown for the event 6 yr old received flublok which is licensed for 18 yrs and older . This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 20.10.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Oropharyngeal pain
Product use issue
Symptomtext
sore throat; Flublok given to 7 yr; Initial information was received on 14-Oct-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves 7 years old female patient who experienced sore throat while receiving vaccine influenza quadrivalent recombinant vaccine [Flublok]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Sep-2022, the patient received suspect influenza quadrivalent recombinant vaccine (lot UJ887AA) (strength, form, dose, frequency, expiry date: unknown) via intramuscular route in unknown administration site for influenza and experienced sore throat (oropharyngeal pain) and (product use issue) (latency: same day). Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Recovered on 21-Sep-2022 for the event sore throat and was Unknown for the event flublok given to 7 yr. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 18.10.2022
- Impfdatum
- 14.10.2022
- Beginn
- 14.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Pruritus
Skin warm
Swelling
Urticaria
Symptomtext
Redness, warmth, swelling, welt like, itchy
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Had Covid on August 2 ( but this is a little over a month prior to vaccination
- Vorgeschichte
- Sinus arrhythmia,
- Andere Medikamente
- Metoprolol, estradiol patch ..05, norethindrone .375 , magnesium OTC,
- Allergien
- Occasional Food intolerance to fresh cherries, apples
- Vorherige Impfungen
- Moderna booster Jan 2022
- Staat
- NY
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 04.10.2022
- Beginn
- 04.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site rash
Injection site swelling
Symptomtext
redness, itchy, rash, swollen, 2-3 inchesa from injection site-bicept area
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- copd
- Andere Medikamente
- crestor, singulair, meloxocam, famotidine, anuera, calcium
- Allergien
- penicillin,
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Balance disorder
Dizziness
Fall
Injection site haemorrhage
Symptomtext
Patient felt dizzy after seeing a small amount of blood at the injection site. She was advised to sit down for 10 to 15 minutes. After a few minutes the patient got up and tried to go to her car to wait it out, but lost her balance and went to her knees. We brought her a chair and gave her water. She was feeling better after a few minutes but had her husband pick her up so she didn't have to drive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none reported
- Andere Medikamente
- unknown
- Allergien
- none
- Vorherige Impfungen
- unknown which vaccine but has fainted before. Patient said it's been a number of years but couldn't give more exact information.
- Staat
- NJ
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 26.09.2022
- Beginn
- 27.09.2022
- Tage bis Beginn
- 1,0
- Dosis
- 7+
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
Patient reported itching and swelling localized to injection area. She showed me a picture of how her arm looked yesterday. There was a approx 2-3" raised red area around site. She denied trouble breathing or swallowing and denied any other issues. Today the site is much smaller. I instructed her to apply a cool compress.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 25.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Oropharyngeal pain
Wrong product administered
Symptomtext
Flublok mistakenly given instead of Fluzone. Tolerated vaccine well. Developed a sore throat on 09/22/2022 but was in contact with sister who had a URI the week prior. Sanofi contacted for information on Flublok in children. Parent notified of error. Given information on trials in children in this age group. Dose does not need to be repeated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Oropharyngeal pain
- Hospital-Tage
- -
- Labordaten
- Was seen in office on 09/24/22 due to sore throat and parent concerned due to recent flu vaccine and flu vaccine error
- Aktuelle Erkrankungen
- started with sore throat the following day
- Vorgeschichte
- none
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 22.06.2023
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to 7 years old child, with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 7 years old male patient and it was reported that flublok(INFLUENZA QUADRIVALENT RECOMBINANT VACCINE) being administered to 7 years old child, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Sep-2022, the patient received a dose of 0.5 ml of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE, injection (strength: unknown) lot UJ887AA, expiry date: 09-Jun-2023, via intramuscular route in the right deltoid as Immunization. On 23-SEP-2022 the flublok being administered to 7 years old child, with no reported adverse event (product administered to patient of inappropriate age) same day following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (FLUBLOK being administered to 7 years old child, with no reported adverse event). At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 28.02.2023
- Impfdatum
- 02.01.2023
- Beginn
- 02.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Product storage error
Symptomtext
Medication error. Covid booster not viable due to improper storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, sleep apnea, diabetes, neuropathy, hyperlipidemia, hypertriglyceridemia
- Andere Medikamente
- aspirin aspirin 81 mg Oral Take by mouth daily. blood sugar diagnostic Blood Sugar Diagnostic E11.9 One Touch Verio test strips. Test two times daily. One or three month supply. blood-glucose meter Blood-Glucose Meter One touch min
- Allergien
- mushroom, penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 27.02.2023
- Impfdatum
- 03.01.2023
- Beginn
- 03.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Product storage error
Symptomtext
Medication error. Vaccine not viable due to improper storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypertension, diabetes, hyperlipidemia, vitamin D deficiency
- Andere Medikamente
- aspirin aspirin 81 mg Oral Take 81 mg by mouth daily. buspirone HCl BUSPAR 10 mg TAKE ONE TABLET BY MOUTH TWICE A DAY ergocalciferol (vitamin D2) DRISDOL 1,250 mcg (50,000 unit) TAKE ONE CAPSULE BY MOUTH ONCE WEEKLY losartan potassium
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 27.02.2023
- Impfdatum
- 03.01.2023
- Beginn
- 03.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Product storage error
Symptomtext
Medication error. Vaccine not viable due to improper temperature storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Cough
- Vorgeschichte
- Hypertension
- Andere Medikamente
- albuterol sulfate PROVENTIL HFA;VENTOLIN HFA 90 mcg/actuation Inhalation Inhale 2 Puffs into the lungs 4 times daily as needed for Wheezing. bupropion HCl WELLBUTRIN SR 150 mg Oral Take 1 Tablet by mouth 2 times daily. lisinopril PRINIVIL
- Allergien
- Penicillins
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 27.02.2023
- Impfdatum
- 09.01.2023
- Beginn
- 09.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Product storage error
Symptomtext
Medication error. Covid vaccine not viable due to improper temperature storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- Sinusitis
- Vorgeschichte
- Hypertension, dyslipidemia, depression
- Andere Medikamente
- aspirin aspirin 81 mg Oral Take 1 Tablet by mouth daily. lisinopril PRINIVIL;ZESTril 20 mg Oral Take 1 Tablet by mouth daily. montelukast sodium SINGULAIR 10 mg Oral Take 1 Tablet by mouth daily. omeprazole PriLOSEC 10 mg Oral Take 2 Cap
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Poor quality product administered
Product storage error
Symptomtext
Medication error. Vaccine not viable due to improper temperature storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- hypertension, diabetes, vitamin D deficiency, vitamin b12 deficiency, hyperlipidemia, depression
- Andere Medikamente
- atorvastatin calcium LIPITOR 10 mg Oral Take 1 Tablet by mouth daily. blood sugar diagnostic OneTouch Verio test strips Misc.(Non-Drug; Combo Route) 1 Strip by Misc.(Non-Drug; Combo Route) route daily. blood-glucose meter Blood-Glucose M
- Allergien
- adhesive tape, codeine
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 24.02.2023
- Impfdatum
- 10.01.2023
- Beginn
- 10.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
Product storage error
Symptomtext
Medication error. Vaccine not viable due to improper temperature storage.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Diabetes, hyperlidemia, vitamin D deficiency, Chron's
- Andere Medikamente
- aspirin aspirin 81 mg Oral Take 81 mg by mouth daily. atorvastatin calcium LIPITOR 20 mg Oral Take 1 Tablet by mouth nightly. azelastine HCl ASTELIN 137 mcg (0.1 %) Each Nare 2 Sprays in each nostril 2 times daily. Use in each nostril as
- Allergien
- Penicillins, metformin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 25.01.2023
- Impfdatum
- 25.01.2023
- Beginn
- 25.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
administered second flu block. Patient, however received on 12/9/22. Patient was notified of med error as of today 1/25/23 no side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- memory loss
- Andere Medikamente
- N/A
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.12.2022
- Impfdatum
- 17.10.2022
- Beginn
- 17.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect product formulation administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Gave FluBlok instead of Fluzone. Individual was 17 not 18 and should have been given Fluzone. NO adverse effects noted by patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect product formulation administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 08.12.2022
- Impfdatum
- 05.10.2022
- Beginn
- 05.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
14y.o patient administered flublok
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.12.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
17 Y.O GIVEN Flublok which is not recommended for use in patients under the age of 18
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 07.12.2022
- Impfdatum
- 03.10.2022
- Beginn
- 03.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Pt was given flublok under age 18. No known adverse effects
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 06.12.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
No adverse event. 10/15/22 Flublock administered instead of fluzone. Provider, self, notifeid 12/6/22. Report made
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 06.12.2022
- Impfdatum
- 29.10.2022
- Beginn
- 29.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse event. Patient, age 16, received FluBlok vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 25.11.2022
- Impfdatum
- 01.11.2022
- Beginn
- 01.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
No adverse event
Symptomtext
When trying to bill the insurance for the vaccine given by our pharmacy, it was then notified that the patient had previously received a flu shot a few months earlier at a clinic in town. The patient is located in a nursing home locally and indicated that they had not received the flu shot and asked to get it. There were no known adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 14.11.2022
- Impfdatum
- 04.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Contusion
Haematoma
Impaired work ability
Symptomtext
THE PATIENT RECIEVED A LARGE BRUSE EXSTENDING BELOW THE ELBOW AND ALMOST THE FULL CIRCUMFERANCE OF THE ARM. AT LEASE 12 INCHES
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Contusion
- Hospital-Tage
- -
- Labordaten
- THE PATENT WENT TO THE ER AND WAS DIAGNOSSED WITH A HEMATOMA AND COULD NOT WORK FOR TWO DAYS
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- DIABETES, HTN, TAKES WARFARIN
- Andere Medikamente
- NOT KNOWN
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 11.11.2022
- Impfdatum
- 15.10.2022
- Beginn
- 15.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient given Flublok age 18+ flu vaccine at age 17
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 22.10.2022
- Impfdatum
- 22.10.2022
- Beginn
- 01.10.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Wrong product administered
Symptomtext
patient given flublok vaccine instead of giving fluzone vaccine. no adverse side effects after injection
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 21.10.2022
- Impfdatum
- 19.10.2022
- Beginn
- 20.10.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
Pt reported having ringing in the ear.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- UNKOWN
- Aktuelle Erkrankungen
- IDK
- Vorgeschichte
- IDK
- Andere Medikamente
- unknown
- Allergien
- Lactose, lisinopril, sulfa, penicillin
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 15.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK Quad was accidentally given to 2 patients under the age of 18 with no reported adverse event; Initial information received on 10-Oct-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case is linked to case 2022SA419831(CLUSTER). This case involves a 12 years old male patient to whom influenza quadrivalent recombinant vaccine [flublok] was accidentally given under the age of 18 with no reported adverse event. On 10-Oct-2022, the patient under the age of 18 received a 0.5 ml (once) dose of suspect influenza quadrivalent recombinant vaccine with no reported adverse event (product administered to patient of inappropriate age) (lot UJ 887AA) via intramuscular route in the left deltoid for immunization. (latency: same day) Action taken: not applicable. Outcome Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 12.10.2022
- Impfdatum
- 10.10.2022
- Beginn
- 10.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Flublok given to a patient that is not 18 years old. Patient had no adverse symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 07.10.2022
- Impfdatum
- 07.10.2022
- Beginn
- 07.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Flublok given to pt <18 . No adverse events
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- ADHD, Depression with anxiety
- Andere Medikamente
- Adderall XR 20mg Caps, Prenatal Vitamin, Depo Provera injection
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 05.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Product use issue
Symptomtext
flublok being administered to pediatric patient with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case is linked to cases 2022SA402510(CLUSTER), 2022SA402530(CLUSTER), 2022SA402436(CLUSTER), 2022SA402500(CLUSTER), 2022SA402514(CLUSTER) and 2022SA402505(CLUSTER). This case involves a 16-year-old female patient to whom Influenza Quadrivalent Recombinant Vaccine [Flublok] being administered to pediatric patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Sep-2022, the patient received 0.5ml total dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE strength: standard (formulation: unknown); Duration of Drug Administration 1 day, (lot number: UJ887AA and expiry date: 09-Jun-2023) via intramuscular route in Left Deltoid for Immunization and it was being administered to pediatric patient with no reported adverse event (product use issue) (latency: unknown). It was reported, this situation is reported as a medication error. Action taken with QUADRIVALENT RECOMBINANT INFLUENZA VACCINE (FLUBLOK) was not applicable. At time of reporting, the outcome was Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Regulatory Authority. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
N/A Wrong vaccine given for age group
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Wrong product administered
Symptomtext
N/A Wrong vaccine given for age group
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Wrong product administered
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 9,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 15.09.2022
- Beginn
- 15.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
n/a wrong vaccination for age group was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse reaction- Missed administration, Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 1,6
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse reaction- Missed administration, Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 1,6
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No adverse reaction- Missed administration, Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Wrong product administered
Symptomtext
n/a wrong vaccination for age group was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 01.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
n/a wrong vaccination for age group was administered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- n.a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 13.09.2022
- Beginn
- 13.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 13.09.2022
- Beginn
- 13.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Missed administration- Vaccine given out of age range.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 11,0
- Geschlecht
- F
- Eingang
- 04.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to pediatric patients with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402707(CLUSTER), 2022SA402396(CLUSTER), 2022SA402443(CLUSTER), 2022SA402500(CLUSTER), 2022SA402505(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402619(CLUSTER), 2022SA402662(CLUSTER), 2022SA402704(CLUSTER), 2022SA402707(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER) and 2022SA402530(CLUSTER). This case involves a 11 years old female patient who was administered Influenza quadrivalent recombinant vaccine [Flublok] at inappropriate age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Sep-2022, the patient had received a dose of 0.5 mL total of suspect Influenza quadrivalent recombinant vaccine standard (lot number UJ887AA, expiry date- 9-Jun-2023) ) (with an unknown formulation) via intramuscular route in the left deltoid for Immunization. On 16-Sep-2022, (latency same day), the patient had developed a non-serious event flublok being administered to pediatric patients with no reported adverse event (product administered to patient of inappropriate age) following the administration of Influenza quadrivalent recombinant vaccine No lab data was reported Action taken with Influenza quadrivalent recombinant vaccine was not applicable. At time of reporting, the outcome was Unknown for the event flublok being administered to pediatric patients with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 13.09.2022
- Beginn
- 13.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to pediatric patients with no reported adverse event; Initial information was received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a healthcare professional. This case is linked to cases 2022SA402396(CLUSTER), 2022SA402443(CLUSTER), 2022SA402505(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402530(CLUSTER), 2022SA402619(CLUSTER), 2022SA402662(CLUSTER), 2022SA402704(CLUSTER), 2022SA402707(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER), 2022SA402530(CLUSTER) and 2022SA402436(CLUSTER). This case involves a 5 years old male patient who was administered Influenza Quadrivalent Recombinant Vaccine [Flublok] at inappropriate age with no reported adverse event. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant vaccinations included: Diphtheria vaccine toxoid, HIB vaccine CONJ (TET TOX), Pertussis vaccine acellular 5-component, polio vaccine INACT 3V (MRC 5), Tetanus vaccine toxoid (Pentacel) for Prophylactic vaccination; Measles vaccine live (ENDERS-Edmonston), Mumps vaccine live (JERYL LYNN), Rubella vaccine live (WISTAR RA 27/3) (MMRVAXPRO) for Prophylactic vaccination; and Varicella zoster vaccine live (OKA/MERCK) (Proquad) for Prophylactic vaccination. On 13-Sep-2022, the patient received suspect Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation, strength: unknown) (lot UJ887AA, expiration date: 09-Jun-2023) via intramuscular route in the left deltoid for Immunization at 5 years of age with no reported adverse event (product administered to patient of inappropriate age). Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PENTACEL; MMRVAXPRO; PROQUAD
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 5,0
- Geschlecht
- M
- Eingang
- 04.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK administered to pediatric patients with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402510(CLUSTER), 2022SA402530(CLUSTER), 2022SA402436(CLUSTER), 2022SA402500(CLUSTER) and 2022SA402443(CLUSTER). This case involves a 5 years pediatric male patient who administered vaccine Influenza Quadrivalent recombinant vaccine [Flublok] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included covid-19 vaccine and diphtheria vaccine toxoid, pertussis vaccine acellular 5-Component, Polio vaccine Inact 3V (MRC 5), tetanus vaccine toxoid (Quadracel). On 12-Sep-2022, the patient received a 0.5 ml dose of suspect Influenza Quadrivalent recombinant vaccine (Frequency: once) (Strength: standard) (form was unknown) (lot number: UJ887AA) (expiry date: 09-Jun-2023) via intramuscular route in the left deltoid for Immunization. On 12-SEP-2022 the pediatric male patient administered vaccine Influenza Quadrivalent recombinant vaccine [Flublok] with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). It was reported Caller reported FLUBLOK administered to 15 pediatric patients and is requesting validity information. Action: not applicable. It was not reported if the patient received a corrective treatment outcome : Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE; QUADRACEL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to pediatric patients with no reported AE; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402396(CLUSTER), 2022SA402436(CLUSTER), 2022SA402500(CLUSTER), 2022SA402707(CLUSTER), 2022SA402704(CLUSTER), 2022SA402662(CLUSTER), 2022SA402619(CLUSTER), 2022SA402525(CLUSTER) and 2022SA402530(CLUSTER). This case involves a 7 months old female patient who experienced flublok being administered to pediatric patients with no reported ae while receiving vaccine influenza quadrivalent recombinant vaccine [flublok]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included hepatitis a vaccine (hepatitis a) for Prophylactic vaccination. On 12-Sep-2022, the patient received a dose of suspect influenza quadrivalent recombinant vaccine lot UJ887AA via intramuscular route in the left vastus lateralis being administered to pediatric patients with no reported ae (product administered to patient of inappropriate age) Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event flublok being administered to pediatric patients with no reported ae. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: influenza quadrivalent recombinant vaccine [flublok].
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- -
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
flublok administered to pediatric patients with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402510(CLUSTER), 2022SA402707(CLUSTER), 2022SA402396(CLUSTER), 2022SA402443(CLUSTER), 2022SA402500(CLUSTER), 2022SA402436(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402505(CLUSTER), 2022SA402704(CLUSTER), 2022SA402707(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER) and 2022SA402530(CLUSTER). This case involves a 11 years old female patient and it was reported that Influenza Quadrivalent Recombinant Vaccine [Flublok] administered to pediatric patients with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included MENINGOCOCCAL VACCINE A/C/Y/W CONJ (TET TOX) (MENQUADFI); and HPV VACCINE VLP RL1 9V (YEAST) (GARDASIL 9). On 23-Sep-2022, the patient received suspect Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation unknown) (lot UJ887AA, expiry date: 09-Jun-2023) standard strength, via intramuscular route in the right deltoid for immunization at 11 years of age with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). Action taken : not applicable. Outcome: unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- MENQUADFI; GARDASIL 9
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 03.10.2022
- Impfdatum
- -
- Beginn
- 13.09.2022
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
flublok being administered to pediatric patients with no adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402510(CLUSTER), 2022SA402530(CLUSTER), 2022SA402436(CLUSTER), 2022SA402500(CLUSTER), 2022SA402443(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402505(CLUSTER) and 2022SA402619(CLUSTER). This case involves a 10 years old male patient to whom INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK].being administered to pediatric patients with no adverse event. The patient's past medical history, medical treatment(s),concomitant medication, vaccination(s) and family history were not provided. On an unknown date, the patient received a 0.5ml dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (strength, formulation was unknown, lot UJ887AA and expiry date: 09-Jun-2023) via intramuscular route in the left deltoid for immunization. On 13-Sep-2022 the patient developed a non-serious event of flublok being administered to pediatric patients with no adverse event (product use issue) (latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 0,6
- Geschlecht
- F
- Eingang
- 03.10.2022
- Impfdatum
- 12.09.2022
- Beginn
- 12.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK administered to pediatric patient with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402707(CLUSTER), 2022SA402396(CLUSTER), 2022SA402443(CLUSTER), 2022SA402500(CLUSTER), 2022SA402436(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402505 (CLUSTER), 2022SA402662(CLUSTER), 2022SA402704(CLUSTER), 2022SA402707(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER) and 2022SA402530(CLUSTER). This case reported a 7 months old female patient and it was reported that Influenza Quadrivalent Recombinant Vaccine [Flublok] administered to pediatric patient with no reported adverse event . The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A). On 12-Sep-2022, the patient received suspect Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation unknown) (lot UJ887AA, exp date: 09-Jun-2023) standard strength, via intramuscular route in the left deltoid for immunization at 7 months of age with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). On 12-Sep-2022 the patient was administered with flubok with no reported adverse event (product administered to patient of inappropriate age) (latency: same day). No lab data was reported Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 23.09.2022
- Beginn
- 23.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK administered to pediatric patient with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402510(CLUSTER), 2022SA402530(CLUSTER), 2022SA402436(CLUSTER) and 2022SA402436(CLUSTER). This case involves a 13 years old female patient who was administered FLUBLOK with no reported adverse event while receiving vaccine INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 23-Sep-2022, the patient received 0.5 mL dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (formulation and strength not reported; lot UJ887AA and expiry date: 09-Jun-2023) via intramuscular route in the left deltoid for prophylactic vaccination. On 23-Sep-2022, (latency: same day) the patient had flublok administered to pediatric patient with no reported adverse event (product use issue) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01296394: 01296472: 01296480: 01296502: 01296512: 01296528: 01296536: 01296543: 01296554: 01296563: 01296570: 01296578: 01296582: 01296616: 01296621:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 10,0
- Geschlecht
- M
- Eingang
- 01.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to pediatric patient, with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402443(CLUSTER), 2022SA402619(CLUSTER), 2022SA402396(CLUSTER), 2022SA402662(CLUSTER), 2022SA402500(CLUSTER), 2022SA402525(CLUSTER), 2022SA402505(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER), 2022SA402530(CLUSTER), 2022SA402436(CLUSTER), 2022SA402514(CLUSTER), 2022SA402964(CLUSTER), 2022SA402707(CLUSTER) and 2022SA402514(CLUSTER). This case involves a 10 years old male patient who was administered Influenza Quadrivalent Recombinant Vaccine [Flublok] at inappropriate age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 16-Sep-2022, the patient received suspect Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation, strength: unknown) (lot UJ887AA, expiry date: 09-Jun-2023) via intramuscular route in the left deltoid for prophylactic immunization at 10 years of age with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). Action taken: was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 15.09.2022
- Beginn
- 15.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Flublok administered to 15 pediatric patients with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases 2022SA402707(CLUSTER), 2022SA402396(CLUSTER), 2022SA402443(CLUSTER), 2022SA402500(CLUSTER), 2022SA402436(CLUSTER), 2022SA402514(CLUSTER), 2022SA402525(CLUSTER), 2022SA402619(CLUSTER), 2022SA402662(CLUSTER), 2022SA402704(CLUSTER), 2022SA402707(CLUSTER), 2022SA402964(CLUSTER), 2022SA402510(CLUSTER) and 2022SA402530(CLUSTER). This case involves a 12 years old female patient who was administered Influenza Quadrivalent Recombinant Vaccine [Flublok] at inappropriate age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 15-Sep-2022, the patient received suspect Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation unknown) (lot UJ887AA, exp date: 09-Jun-2023) standard strength, via intramuscular route in the left deltoid for immunization at 12 years of age with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day). On 15-Sep-2022 the patient was administered with flubok with no reported adverse event (product administered to patient of inappropriate age) 1 day following the administration of vaccine. No lab data was reported Action taken was not applicable. At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 14.09.2022
- Beginn
- 14.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to 12 year old with no reported adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA402510(CLUSTER). This case involves a 12 years old female patient who was administered Influenza Quadrivalent Recombinant Vaccine [Flublok] at inappropriate age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included COVID-19 VACCINE (COVID-19 VACCINE) for Immunisation. On 14-Sep-2022, the patient of 12 year received Influenza Quadrivalent Recombinant Vaccine at dose of 0.5 ml, once (formulation, strength: unknown) (lot UJ887AA, exp date: 09-Jun-2023) via intramuscular route in the left deltoid for Immunization with no reported adverse event (product administered to patient of inappropriate age). Action taken not applicable. At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 01.10.2022
- Impfdatum
- 16.09.2022
- Beginn
- 16.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK being administered to pediatric patients; 12 years with reported no adverse event; Initial information received on 27-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to cases CLUSTER: 2022SA402396, 2022SA402704, 2022SA402436, 2022SA402443, 2022SA402500, 2022SA402505, 2022SA402514, 2022SA402525, 2022SA402530, 2022SA402619, 2022SA402662, 2022SA402707, 2022SA402718 and 2022SA402964. This case involves a 12 years old female patient who was reported with flublok being administered to pediatric patients; 12 years with reported no adverse event while receiving vaccine influenza quadrivalent recombinant vaccine[Flublok]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV vaccine VLP RL1 9V (yeast) (Gardasil 9) for Immunisation. On 16-Sep-2022, the patient received a 1 dose of suspect influenza quadrivalent recombinant vaccine at a dose of 0.5 ml once with standard strength (lot UJ887AA, expiry date- 09-Jun-2023) (with unknown formulation) via intramuscular route in the left deltoid for Immunisation. On 16-Sep-2022 the flublok being administered to pediatric patients; 12 years with reported no adverse event (product administered to patient of inappropriate age) (latency: same day) following the administration of vaccine. Action taken was not applicable. At time of reporting, the outcome was Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- GARDASIL 9
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 30.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
FLUBLOK was given to two patients under 18 years of age with no reported adverse event; Initial information received on 21-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA393474(CLUSTER). This case involves a 7 years old female patient who was under 18 years of age and given INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Sep-2022, the patient received 0.5 ml, once dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (lot UJ887AA, exp: 09-Jun-2023) via intramuscular route in the left deltoid for immunisation. On 21-Sep-2022 the patient developed a non-serious "Flublok was given to two patients under 18 years of age with no reported adverse event" (product administered to patient of inappropriate age) (latency: same day) following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken: not applicable. At time of reporting, the outcome was unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 28.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Administration of FLUBLOK to patient under 18 years of age with no reported adverse event; Initial information received on 21-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case is linked to case 2022SA393689(CLUSTER). This case involves a 6 years old female patient to whom influenza quadrivalent recombinant vaccine [Flublok] administered to patient under 18 years of age with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 21-Sep-2022, the patient received 0.5 ml dose once of suspect influenza quadrivalent recombinant vaccine (strength and formulation not reported) (lot UJ887AA; Expiry date: 09-Jun-2023) via intramuscular route in the left deltoid for immunization to patient under 18 years of age with no reported adverse event (product administered to patient of inappropriate age) (latency; on same day). Action taken :not applicable. Outcome : Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 25.09.2022
- Impfdatum
- 21.09.2022
- Beginn
- 21.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Somnolence
Wrong product administered
Symptomtext
Flublok given in error instead of fluzone for age group. Side effect: was very sleepy/groggy that night, fine by next morning.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- URI week prior
- Vorgeschichte
- none known
- Andere Medikamente
- none known
- Allergien
- Amoxicillin/cefaclor: red bumpy rash: new patient to our practice, unknown if true allergy or not
- Vorherige Impfungen
- -